BMRN
BIOMARIN PHARMACEUTICAL INC
Key Financials
Revenue
$3.2B
↑ 12.9%
Net Income
$348.9M
↓ 18.3%
Operating Income
$409.5M
↓ 15.4%
Total Assets
$7.6B
↑ 8.7%
Shareholders' Equity
$6.1B
↑ 7.6%
Cash & Equivalents
$1.3B
↑ 39.1%
EPS (Diluted)
$1.80
↓ 18.6%
Total Liabilities
$1.5B
↑ 13.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BMRN |
| Company Name | BIOMARIN PHARMACEUTICAL INC |
| CIK | 1048477 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 4155066700 |